Related Experiment Videos
Studies of lung infections caused by Pseudomonas aeruginosa in mice treated with cyclophosphamide
Abstract:
An experimental Pseudomonas aeruginosa lung infection was induced by aerosol exposure in mice which had been pretreated with cyclophosphamide. A single dose of 200 mg/kg cyclophosphamide resulted in leukopenia which lasted for three days. At the lowest PMN levels, the mice were exposed to aerosols containing varying doses of bacteria. The survival time of the mice and the number of viable bacteria in their lungs were determined. A dramatic rise in the viable counts of Pseudomonas organisms was found between 18 and 24 hours after infection. Mice which had not been pretreated with cyclophosphamide remained healthy and did not show any lung lesions. The number and phagocytic function of the alveolar macrophages remained unaltered after cyclophosphamide treatment. Thus, PMNs seem to play an important role in the lung's early defence mechanisms against Pseudomonas aeruginosa. This animal model could be of use in evaluating additional therapies for lung infections caused by Pseudomonas aeruginosa.
Insights
Cyclophosphamide-induced leukopenia in mice revealed the critical role of polymorphonuclear neutrophils (PMNs) in combating Pseudomonas aeruginosa lung infections. This model aids in developing new therapies for bacterial lung infections.
Area of Science:
- Infectious Diseases
- Immunology
- Pulmonology
Background:
- Pseudomonas aeruginosa is a significant opportunistic pathogen causing severe lung infections.
- Neutrophils play a crucial role in host defense against bacterial infections.
- Cyclophosphamide is an immunosuppressive drug that can induce leukopenia.
Purpose of the Study:
- To investigate the role of polymorphonuclear neutrophils (PMNs) in the early defense against Pseudomonas aeruginosa lung infection.
- To establish a mouse model for studying Pseudomonas aeruginosa lung infections.
Main Methods:
- Aerosolized Pseudomonas aeruginosa infection was induced in mice pretreated with cyclophosphamide to induce leukopenia.
- Survival time and bacterial lung counts were assessed.
- Alveolar macrophage function was evaluated.
Main Results:
- Cyclophosphamide treatment led to significant leukopenia, reducing PMN levels for three days.
- Mice with reduced PMN levels showed a dramatic increase in viable Pseudomonas aeruginosa counts within 18-24 hours.
- Control mice (without cyclophosphamide) remained healthy with no lung lesions.
- Alveolar macrophage number and phagocytic function were unaffected by cyclophosphamide.
Conclusions:
- Polymorphonuclear neutrophils (PMNs) are essential for the early lung defense against Pseudomonas aeruginosa.
- The developed animal model is suitable for evaluating novel therapies for Pseudomonas aeruginosa lung infections.